Photodynamic Therapy (PDT) is a noninvasive medical treatment consisting of ROS production with the excitation of a photosensitizing molecule (PS) using a suitable light. The excited PS undergoes intersystem crossing from the singlet to the triplet excited state, where, in Type II PDT, its energy transfers to molecular O2, generating the cytotoxic 1O2. A promising PS for PDT is Ru-phenAN, a polyamidoamine polymer bearing a Ru(II) complex, prepared and characterized by our research groups. Ru-phenAN has been proven to produce 1O2 with a good yield and to be efficiently internalized by cells. Furthermore, when irradiated, Ru-phenAN promotes endosomal escape and accumulates in the nucleus, increasing the effectiveness of its use for PDT. In this ongoing project, we functionalized the surface of gold nanostars (GNSs) with Ru-phenAN to test whether the metal core might increase 1O2 generation through an energy transfer to the photosensitizer via Localized Surface Plasmonic Resonance (LSPR), hence increasing PDT efficacy. GNS@Ru-phenAN nanoparticles were prepared by using a layer-by-layer approach: first a layer of a negatively charged polyamidoamine was adsorbed on the GNS, then Ru-phenAN in order to increase the distance between the Ru-phenAN and the metal core. The size, z-potential and stability of the nanoparticles in water and PBS were characterized, as well as their absorption and emission spectra. Uptake by Hela cells was then measured and compared to Ru-phenAN alone, showing a comparable internalization and emission inside the cells. Next, the cytotoxicity and the production of reactive oxygen species (ROS) of the Ru-phenAN polymer, GNS@Ru-phenAN and the bare GNSs have been compared, both in the dark and after irradiation in the visible spectral range. GNS@Ru-phenAN nanoparticles were prepared by using a layer-by-layer approach: first a layer of a negatively charged polyamidoamine was adsorbed on the GNS, then Ru-phenAN in order to increase the distance between the Ru-phenAN and the metal core. The size, z-potential and stability of the nanoparticles in water and PBS were characterized, as well as their absorption and emission spectra. Uptake by Hela cells was then measured and compared to Ru-phenAN alone, showing a comparable internalization and emission inside the cells. Next, the cytotoxicity and the production of reactive oxygen species (ROS) of the Ru-phenAN polymer, GNS@Ru-phenAN and the bare GNSs have been compared, both in the dark and after irradiation in the visible spectral range. The results obtained so far showed an increase in 1O2 production and cytotoxicity for the GNS@Ru-phenAN compared to the Ru-phenAN alone after irradiation, suggesting that adsorption onto the gold nanostars may be used to enhance Ru-phenAN efficacy in PDT.
Decoration of gold nanostars with a polyamidoamine-Ru(II) complex to increase 1O2 generation efficiency in Photodynamic Therapy / V. Schifano, A. Salvati, D. Maggioni. Pharmacy Day of Groningen Research Institute of Pharmacy Groningen 2025.
Decoration of gold nanostars with a polyamidoamine-Ru(II) complex to increase 1O2 generation efficiency in Photodynamic Therapy
V. SchifanoPrimo
;D. MaggioniCo-ultimo
2025
Abstract
Photodynamic Therapy (PDT) is a noninvasive medical treatment consisting of ROS production with the excitation of a photosensitizing molecule (PS) using a suitable light. The excited PS undergoes intersystem crossing from the singlet to the triplet excited state, where, in Type II PDT, its energy transfers to molecular O2, generating the cytotoxic 1O2. A promising PS for PDT is Ru-phenAN, a polyamidoamine polymer bearing a Ru(II) complex, prepared and characterized by our research groups. Ru-phenAN has been proven to produce 1O2 with a good yield and to be efficiently internalized by cells. Furthermore, when irradiated, Ru-phenAN promotes endosomal escape and accumulates in the nucleus, increasing the effectiveness of its use for PDT. In this ongoing project, we functionalized the surface of gold nanostars (GNSs) with Ru-phenAN to test whether the metal core might increase 1O2 generation through an energy transfer to the photosensitizer via Localized Surface Plasmonic Resonance (LSPR), hence increasing PDT efficacy. GNS@Ru-phenAN nanoparticles were prepared by using a layer-by-layer approach: first a layer of a negatively charged polyamidoamine was adsorbed on the GNS, then Ru-phenAN in order to increase the distance between the Ru-phenAN and the metal core. The size, z-potential and stability of the nanoparticles in water and PBS were characterized, as well as their absorption and emission spectra. Uptake by Hela cells was then measured and compared to Ru-phenAN alone, showing a comparable internalization and emission inside the cells. Next, the cytotoxicity and the production of reactive oxygen species (ROS) of the Ru-phenAN polymer, GNS@Ru-phenAN and the bare GNSs have been compared, both in the dark and after irradiation in the visible spectral range. GNS@Ru-phenAN nanoparticles were prepared by using a layer-by-layer approach: first a layer of a negatively charged polyamidoamine was adsorbed on the GNS, then Ru-phenAN in order to increase the distance between the Ru-phenAN and the metal core. The size, z-potential and stability of the nanoparticles in water and PBS were characterized, as well as their absorption and emission spectra. Uptake by Hela cells was then measured and compared to Ru-phenAN alone, showing a comparable internalization and emission inside the cells. Next, the cytotoxicity and the production of reactive oxygen species (ROS) of the Ru-phenAN polymer, GNS@Ru-phenAN and the bare GNSs have been compared, both in the dark and after irradiation in the visible spectral range. The results obtained so far showed an increase in 1O2 production and cytotoxicity for the GNS@Ru-phenAN compared to the Ru-phenAN alone after irradiation, suggesting that adsorption onto the gold nanostars may be used to enhance Ru-phenAN efficacy in PDT.| File | Dimensione | Formato | |
|---|---|---|---|
|
Abstract+Pharmacy+Day+Schifano+Veronica.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Licenza:
Creative commons
Dimensione
70.37 kB
Formato
Adobe PDF
|
70.37 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




